Your browser doesn't support javascript.
loading
Primary Hyperoxaluria Type 1 Disease Manifestations and Healthcare Utilization: A Multi-Country, Online, Chart Review Study.
Wang, Xiangling; Danese, David; Brown, Thomas; Baldwin, Jessica; Sajeev, Gautam; Cook, Erin E; Wang, Yao; Xu, Chunyi; Yang, Hongbo; Moritz, Michael L.
Affiliation
  • Wang X; Center for Personalized Genetic Healthcare, Department of Nephrology and Hypertension, Department of Molecular Medicine, Cleveland Clinic, Cleveland, OH, United States.
  • Danese D; Alnylam Pharmaceuticals, Inc., Cambridge, MA, United States.
  • Brown T; Alnylam Pharmaceuticals, Inc., Cambridge, MA, United States.
  • Baldwin J; Alnylam Pharmaceuticals, Inc., Cambridge, MA, United States.
  • Sajeev G; Analysis Group, Inc., Boston, MA, United States.
  • Cook EE; Analysis Group, Inc., Boston, MA, United States.
  • Wang Y; Analysis Group, Inc., Boston, MA, United States.
  • Xu C; Analysis Group, Inc., Boston, MA, United States.
  • Yang H; Analysis Group, Inc., Boston, MA, United States.
  • Moritz ML; Division of Nephrology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Front Med (Lausanne) ; 8: 703305, 2021.
Article in En | MEDLINE | ID: mdl-34616753

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Implementation_research Language: En Journal: Front Med (Lausanne) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Implementation_research Language: En Journal: Front Med (Lausanne) Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland